Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cost Effectiveness and Resource Allocation
Published in: Cost Effectiveness and Resource Allocation 1/2023

Open Access 01-12-2023 | Trapeziectomy | Research

Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study

Authors: Alfred P. Yoon, David W. Hutton, Kevin C. Chung

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2023

Login to get access

Abstract

Background

Thumb carpometacarpal (CMC) joint arthritis is one of the most prevalent arthritic conditions commonly treated with trapeziectomy alone or trapeziectomy with ligament reconstruction and tendon interposition (LRTI). We evaluate the cost-effectiveness and value of perfect and sample information of trapeziectomy alone, LRTI, and non-operative treatment.

Methods

A societal perspective decision tree was modeled. To understand the value of future research in comparing quality-of-life after trapeziectomy, LRTI, and non-operative management we characterized uncertainty by fitting distributions to EQ-5D utility data published from the United Kingdom hand surgery registry. We used Monte Carlo simulation for the probabilistic sensitivity analysis and to evaluate the value of perfect and sample information.

Results

Both trapeziectomy alone and LRTI were cost-effective compared to non-operative management ($2,540 and $3,511/QALY respectively). Trapeziectomy alone (base case total cost $8,251, QALY 14.08) was dominant compared to LRTI (base case total cost $8,798, QALY 13.34). However, probabilistic sensitivity analysis suggested there is a 12.5% chance LRTI may be preferred at a willingness-to-pay of $50,000/QALY. Sensitivity analysis revealed postoperative utilities are the most influential factors in determining cost-effectiveness. The value of perfect information was approximately $1,503/person. A study evaluating the quality-of-life of 1,000 patients in each arm undergoing trapeziectomy alone or LRTI could provide an expected $1,117 of information value. With approximately 40,000 CMC arthroplasties performed each year in the U.S., the annual value is close to $45 million.

Conclusions

Trapeziectomy without LRTI appears to be the most cost-effective procedure in treating late-stage CMC arthritis and should be considered as first-line surgical treatment. There is substantial societal value in conducting additional research to better understand the relative quality-of-life improvements gained from these two common hand surgeries.
Appendix
Available only for authorised users
Literature
1.
Batra S, Kanvinde R. Osteoarthritis of the thumb trapeziometacarpal joint. Curr Orthop. 2007;21(2):135–44.CrossRef
2.
Haara MM, Heliövaara M, Kröger H, Arokoski JP, Manninen P, Kärkkäinen A, et al. Osteoarthritis in the carpometacarpal joint of the thumb. Prevalence and associations with disability and mortality. J Bone Joint Surg Am. 2004;86(7):1452–7.PubMedCrossRef
3.
Sodha S, Ring D, Zurakowski D, Jupiter JB. Prevalence of osteoarthrosis of the trapeziometacarpal joint. J Bone Joint Surg Am. 2005;87(12):2614–8.PubMedCrossRef
4.
5.
Heyworth BE, Lee JH, Kim PD, Lipton CB, Strauch RJ, Rosenwasser MP. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J Hand Surg Am. 2008;33(1):40–8.PubMedCrossRef
6.
Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies including therapeutics (ESCISIT). Ann Rheum Dis. 2007;66(3):377–88.PubMedCrossRef
7.
Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol. 2002;156(11):1021–7.PubMedCrossRef
8.
Deutch Z, Niedermeier SR, Awan HM. Surgeon preference, influence, and treatment of Thumb Carpometacarpal Arthritis. Hand. 2018;13(4):403–11.PubMedCrossRef
9.
Wolf JM, Delaronde S. Current trends in nonoperative and operative treatment of trapeziometacarpal osteoarthritis: a survey of US hand surgeons. J Hand Surg Am. 2012;37(1):77–82.PubMedCrossRef
10.
Belcher HJ, Nicholl JE. A comparison of trapeziectomy with and without ligament reconstruction and tendon interposition. J Hand Surg Br. 2000;25(4):350–6.PubMedCrossRef
11.
Vermeulen GM, Slijper H, Feitz R, Hovius SE, Moojen TM, Selles RW. Surgical management of primary thumb carpometacarpal osteoarthritis: a systematic review. J Hand Surg Am. 2011;36(1):157–69.PubMedCrossRef
12.
Gangopadhyay S, McKenna H, Burke FD, Davis TR. Five- to 18-year follow-up for treatment of trapeziometacarpal osteoarthritis: a prospective comparison of excision, tendon interposition, and ligament reconstruction and tendon interposition. J Hand Surg Am. 2012;37(3):411–7.PubMedCrossRef
13.
Davis TR, Brady O, Dias JJ. Excision of the trapezium for osteoarthritis of the trapeziometacarpal joint: a study of the benefit of ligament reconstruction or tendon interposition. J Hand Surg Am. 2004;29(6):1069–77.PubMedCrossRef
14.
Naram A, Lyons K, Rothkopf DM, Calkins ER, Breen T, Jones M, et al. Increased complications in trapeziectomy with ligament reconstruction and tendon interposition compared with trapeziectomy alone. Hand. 2016;11(1):78–82.PubMedPubMedCentralCrossRef
15.
Davis T, Brady O, Barton N, Lunn P, Burke F. Trapeziectomy alone, with tendon interposition or with ligament reconstruction? A randomized prospctive study. J Hand Surg Br. 1997;22(6):689–94.PubMedCrossRef
16.
Wajon A, Vinycomb T, Carr E, Edmunds I, Ada L. Surgery for thumb (trapeziometacarpal joint) osteoarthritis. Cochrane Database Syst Rev. 2015;2015(2):Cd004631.PubMedPubMedCentral
17.
Tuffaha HW, Gordon LG, Scuffham PA. Value of information analysis in healthcare: a review of principles and applications. J Med Econ. 2014;17(6):377–83.PubMedCrossRef
18.
De Smet L, Sioen W, Spaepen D, Van Ransbeeck H. Treatment of basal joint arthritis of the thumb: trapeziectomy with or without tendon interposition/ligament reconstruction. Hand Surg. 2004;9(01):5–9.PubMedCrossRef
19.
De Smet L, Vandenberghe L, Degreef I. Long-term outcome of trapeziectomy with ligament reconstruction and tendon interposition (LRTI) versus prosthesis arthroplasty for basal joint osteoarthritis of the thumb. Acta Orthop Belg. 2013;79(2):146–9.PubMed
20.
Hippensteel K, Calfee R, Dardas AZ, Gelberman R, Osei D, Wall L. Functional outcomes of thumb trapeziometacarpal arthrodesis with a locked plate versus ligament reconstruction and tendon interposition. J Hand Surg Am. 2017;42(9):685–92.PubMedCrossRef
21.
Mureau MA, Rademaker RP, Verhaar JA, Hovius SE. Tendon interposition arthroplasty versus arthrodesis for the treatment of trapeziometacarpal arthritis: a retrospective comparative follow-up study. J Hand Surg Am. 2001;26(5):869–76.PubMedCrossRef
22.
Salem H, Davis T. Six year outcome excision of the trapezium for trapeziometacarpal joint osteoarthritis: is it improved by ligament reconstruction and temporary Kirschner wire insertion? J Hand Surg Eur Vol. 2012;37(3):211–9.PubMedCrossRef
23.
Kriegs-Au G, Petje G, Fojtl E, Ganger R, Zachs I. Ligament reconstruction with or without tendon interposition to treat primary thumb carpometacarpal osteoarthritis: a prospective randomized study. J Bone Joint Surg Am. 2004;86(2):209–18.PubMedCrossRef
24.
Cannon NM, Beal B, Walters K. Diagnosis and treatment manual for physicians and therapists. Indianapolis: The Hand Center of Indiana PC; 2020.
25.
26.
Speich B, von Niederhäusern B, Schur N, Hemkens LG, Fürst T, Bhatnagar N, et al. Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data. J Clin Epidemiol. 2018;96:1–11.PubMedCrossRef
27.
Lane JCE, Rodrigues JN, Furniss D, Burn E, Poulter R, Gardiner MD. Basal thumb osteoarthritis surgery improves health state utility irrespective of technique: a study of UK Hand Registry data. J Hand Surg Eur. 2020;45(5):436–42.CrossRef
28.
Brazzelli M, Cruickshank M, Tassie E, McNamee P, Robertson C, Elders A, et al. Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation. Health Technol Assess. 2015;19(90):1–202.PubMedPubMedCentralCrossRef
29.
30.
Thorkildsen RD, Røkkum M. Trapeziectomy with LRTI or joint replacement for CMC1 arthritis, a randomised controlled trial. J Plast Surg Hand Surg. 2019;53(6):361–9.PubMedCrossRef
31.
32.
33.
Yokota F, Thompson KM. Value of information literature analysis: a review of applications in health risk management. Med Decis Making. 2004;24(3):287–98.PubMedCrossRef
34.
Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796–7.PubMedCrossRef
35.
Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn’t it increase at the rate of inflation? Arch Intern Med. 2003;163(14):1637–41.PubMedCrossRef
36.
Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making. 1986;6(2):85–92.PubMedCrossRef
37.
Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985;5(2):157–77.PubMedCrossRef
38.
Thompson KM, Burmaster DE, Crouch EA. Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments. Risk Anal. 1992;12(1):53–63.PubMedCrossRef
39.
Hatswell AJ, Bullement A, Briggs A, Paulden M, Stevenson MD. Probabilistic sensitivity analysis in cost-effectiveness models: determining Model Convergence in Cohort Models. PharmacoEconomics. 2018;36(12):1421–6.PubMedCrossRef
40.
Efanov JI, Nguyen DD, Izadpanah A, Danino MA, Harris P. A health utility assessment of trapeziectomy with ligament reconstruction and tendon interposition for thumb trapeziometacarpal osteoarthritis. J Hand Surg Eur. 2019;44(7):722–7.CrossRef
41.
Mooney C, Mushlin AI, Phelps CE. Targeting assessments of magnetic resonance imaging in suspected multiple sclerosis. Med Decis Making. 1990;10(2):77–94.PubMedCrossRef
42.
Claxton KP, Sculpher MJ. Using value of information analysis to prioritise health research. PharmacoEconomics. 2006;24(11):1055–68.PubMedCrossRef
43.
Claxton K, Neumann PJ, Araki S, Weinstein MC. Bayesian value-of-information analysis: an application to a policy model of Alzheimer’s disease. Int J Technol Assess Health Care. 2001;17(1):38–55.PubMedCrossRef
44.
Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making. 2015;35(1):114–31.PubMedCrossRef
45.
Grimm SE, Dixon S, Stevens JW. Assessing the expected value of research studies in reducing uncertainty and improving implementation dynamics. Med Decis Making. 2017;37(5):523–33.PubMedCrossRef
46.
Thoma A, Levis C, Patel P, Murphy J, Duku E. Partial versus total trapeziectomy thumb arthroplasty: an expertise-based feasibility study. Plast Reconstr Surg Glob Open. 2018;6(3):e1705.PubMedPubMedCentralCrossRef
Metadata
Title
Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study
Authors
Alfred P. Yoon
David W. Hutton
Kevin C. Chung
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2023
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/s12962-023-00438-8

Other articles of this Issue 1/2023

Cost Effectiveness and Resource Allocation 1/2023 Go to the issue

Methodology

Framework for determining the optimal course of action when efficiency and affordability measures differ by perspective in cost-effectiveness analysis—with an illustrative case of HIV treatment in Mozambique

Research

Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration

Research

Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis

Research

One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis

Methodology

Stochastic cost-effectiveness analysis on population benefits

Research

Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis